ALNYLAM PHARMACE.DL-,0001

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ALNYLAM PHARMACE.DL-,0001 stocks are traded under the ticker DUL.

ALNYLAM PHARMACE.DL-,0001 is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for ALNYLAM PHARMACE.DL-,0001 has a max estimate of 371.75 EUR and a min estimate of 128.00 EUR.

DUL earnings for the last quarter are 1.09 EUR whereas the estimation was −1.37 EUR which accounts for 179.55% surprise. Estimated earnings for the next quarter are −1.07 EUR. See more details about ALNYLAM PHARMACE.DL-,0001 earnings.

ALNYLAM PHARMACE.DL-,0001 revenue for the last quarter amounts to ‪710.00 M‬ EUR despite the estimated figure of ‪375.33 M‬ EUR. In the next quarter revenue is expected to reach ‪395.85 M‬ EUR.

Yes, you can track ALNYLAM PHARMACE.DL-,0001 financials in yearly and quarterly reports right on TradingView.

No, DUL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, DUL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALNYLAM PHARMACE.DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.

DUL reached its all-time high on Aug 15, 2022 with the price of 227.20 EUR, and its all-time low was 4.35 EUR and was reached on Aug 11, 2011.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has ‪2.10 K‬ employees. See our rating of the largest employees — is ALNYLAM PHARMACE.DL-,0001 on this list?

We've gathered analysts' opinions on ALNYLAM PHARMACE.DL-,0001 future price: according to them, DUL price has a max estimate of 371.77 EUR and a min estimate of 128.00 EUR. Read a more detailed ALNYLAM PHARMACE.DL-,0001 forecast: see what analysts think of ALNYLAM PHARMACE.DL-,0001 and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALNYLAM PHARMACE.DL-,0001 EBITDA is ‪−206.68 M‬ EUR, and current EBITDA margin is −12.48%. See more stats in ALNYLAM PHARMACE.DL-,0001 financial statements.